Crinetics Pharmaceuticals Announces Upcoming Presentations at ENDO2019
March 14, 2019 16:27 ET
|
Crinetics Pharmaceuticals, Inc.
SAN DIEGO, March 14, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of...
Crinetics Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
January 02, 2019 16:05 ET
|
Crinetics Pharmaceuticals, Inc.
SAN DIEGO, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of...
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Netshoes (Cayman) Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
December 04, 2018 14:26 ET
|
Schall Law
LOS ANGELES, Dec. 04, 2018 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Netshoes...
PROVECTUS ANNOUNCES PRESENTATION OF PHASE 1 TRIAL OF PV-10 FOR TREATMENT OF SYMPTOMATIC NEUROENDOCRINE TUMORS METASTATIC TO LIVER AT ESMO 2018 CONGRESS
October 23, 2018 09:00 ET
|
Provectus Biopharmaceuticals Inc.
- First cohort of 6 patients enrolled and treated; currently recruiting patients into second cohort KNOXVILLE, TN, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that...
Canadian government inadequately addressing one of the biggest threats to our oceans
May 03, 2017 08:00 ET
|
Oceana Canada
TORONTO, ON--(Marketwired - May 03, 2017) - A report released today from Oceana Canada -- Collateral damage: How to reduce bycatch in Canada's commercial fisheries -- reveals how poorly Canada is...